2008 Barcelona - European Society of Human Genetics

Keyword Index
MLH1: P04.010, P04.022, P04.023, P04.204
MLL: P04.095
MLPA (multiplex ligation dependent probe
amplifica: P06.315
MLPA: P01.103, P01.115, P01.221, P01.320,
P01.362, P02.001, P02.008, P02.014,
P02.015, P02.050, P02.074, P03.11, P03.51,
P03.52, P03.62, P04.027, P05.095, P05.120,
P05.183, P06.183, P06.184, P08.50, P08.63
MLS: P01.321
MMP20: P05.005
MMR: P04.016
Modifiers: P07.064
modifying factor: P05.036
modulation factors: P01.105
MODY3: P05.131
moebius syndrome: P01.322
Molar Tooth Sign: P01.309
Molecular Analysis: P05.032
molecular basis: P01.011
Molecular Biomarkers: S03.4
Molecular cytogenetics: P02.168, P02.196
molecular defects: P01.201
molecular diagnosis: P04.065
molecular diagnostics: P01.024, P01.287
Molecular Genetics testing: P09.44
molecular genetics: P01.156, P01.279,
P09.55
molecular interaction networks: S12.2
molecular profiling: P04.014, S12.1
MOMO syndrome: P01.323
Monilethrix: P05.213
monosomy 21: P02.169
monosomy 3: P04.205
monosomy 3p: P02.210
Monozygotic twins: P06.126
monozygotic: P01.044
Mood Disorder: P06.001, P06.121
Mood disorders: P06.177
morbidity: P09.52
Morgagni: P02.139
Morocco: P07.023
Morpholino Antisense Oligonucleotides
(AMOs): C15.2
Morquio IVB type: P01.043
Mosaic aneuploidy: P03.53
mosaic NF1: P01.197
mosaic trisomy 22: P01.324
mosaic: P02.215
mosaicism: P01.166, P02.084, P02.102,
P02.113, P03.45, P03.63, P05.132, P05.146
MOTIVATION: EPL3.3
motor neuron disease: P06.018
MOTOR NEURON: P05.181
mouse models: P08.61
Mowat-Wilson syndrome: P01.326
Mowat-Wilson: P01.325
MPNST: P01.194
MPS 1: P01.044
MPZ: P01.226, P01.256
MRI: P01.274
mRNA decay: P01.162
mRNA expression: P08.66
mRNA: P01.038
MRP1: P04.097, P04.098
MRT3: C14.3
MSH2: P04.010, P04.017, P04.024
MSH6: P04.011
MS-MLPA: P01.090, P02.055, P02.058,
P02.060
MSUD: P09.22
MSX1 gene: P06.185
mt DNA: P07.084
mtDNA: P04.142, P05.064, P05.130,
P06.298, P07.065, P07.135
MTHFR C677T: P06.065
MTHFR polymorphism: P04.163
MTHFR severe deficiency: P05.134
MTHFR: P05.133, P05.197, P06.050,
P06.186, P06.187, P06.204, P06.278, P08.55
MTHFR-C677T variant: P07.091
mTOR: P04.123
MTR: P04.164
Mucopolysaccharidosis VII: P01.327
Muliple Sclerosis: P05.125
multicultural: EP10.12, P09.18
multidisciplinary approach: C11.4
Multidisciplinary: EP05.2
Multidrug Resistance Protein 1: P07.027
multiple congenital anomalies: P02.130
multiple congenital anomaly syndrome:
P01.096
Multiple endocrine neoplasia type 2A
(MEN2A): EP13.8
multiple endocrine neoplasia: P04.165
Multiple Ligation Probe Amplification:
P02.125
multiple malformations: P01.330
multiple myeloma: P04.114, P06.074
multiple primary tumors: P04.166
Multiple sclerosis: P01.345, P05.191,
P06.010, P06.188, P06.189, P06.190,
P06.191, P06.192, P06.193, P06.197,
P07.067
Multiple sulfatase deficiency: P01.061
Multiplex Assays: P07.074
Multiplex Ligation Probe Amplification:
P08.45
multiplex ligation-dependent amplification
(MLPA): P01.238
Multiplex PCR: P06.191
multiplex STRs: P04.094
multiplex: P08.74
multisystem type I pseudohypoaldosteronism:
P01.328
Multple osteochondromas: P01.160
Mulvihill-Smith: P01.329
Munc13-4 mutations: P05.040
muscle fiber: P06.309
muscle: P01.306
muscular disorders: P05.124
muscular dystrophy: P08.25
muscular weakness: P01.206
Muscular: P07.119
musical aptitude: P06.194
muslim world: EP10.11
mutation 35delG and M34T: P07.092
mutation analysis: P01.040, P05.117,
P06.248
Mutation database: P08.15
mutation detection: P04.031, P05.148,
P06.195
mutation scanning: P04.026, P06.196
mutation screening: P06.093, P06.290
mutation/expression: P04.176
Mutation: P01.005, P01.006, P01.017,
P01.038, P01.062, P01.159, P01.179,
P01.205, P01.209, P01.242, P01.294,
P01.369, P01.370, P04.062, P04.159,
P05.061, P05.075, P05.110, P05.156,
P05.173, P06.125, P06.201, P06.211,
P06.234, P08.10, P08.11, P08.56, P08.57,
PL2.4
mutations: P01.056, P01.200, P04.001,
P04.092, P04.127, P05.053, P05.064,
P05.065, P05.119, P05.135, P06.019,
P06.149, P08.79
MUTYH: P04.004
MUTYH-associated polyposis: P04.025
MyBPC3: P01.300, P01.301
myelin: P05.136
Myelodysplastic Syndrome: P04.107,
P04.109
myelodysplastic syndromes: P04.071
myelodysplastic: P04.115
Myelodysplatic syndrome: P04.116
myeloid leukemia: P04.077
Myeloperoxidase: P06.226
Myeloproliferative disorders: P04.117
myeloproliferative neoplasms: P04.083
myeloproliferative: P04.115
MYH: P04.011
MYH7: P05.065
MYO9B: P06.197
MYOC: P06.241
myocardial infarction: P05.137, P05.138,
P06.198
Myocilin: P05.057
myopathy: P01.206
myopathyc process: P05.133
myopia: P06.199
Myosin Binding Protein C: P05.090
Myotonia congenita: P01.212, P05.023
myotonia: P06.302
Myotonic dystrophy type 1: P01.215
Myotonic dystrophy type 1: P01.224,
P05.032
Myotonic Dystrophy: EPL6.2, P01.213,
P01.214, P06.200
Na Channelopathy: P05.177
Nager syndrome: P03.49
Nahuas: P07.032
Nail-patella syndrome: P01.330, P06.201
NAIP: P01.216
narrative perspective: EP10.21
Narrow chest: P01.143
NASBA: P08.51
NAT2: P06.011, P06.047, P06.289
natural autoantibodies: P06.202
Natural background radiation: P07.029
natural selection: P06.262, P06.263